Papilomatose de laringe

Authors

  • Carla von Mülen
  • Cristiane Rigol
  • Raquel Melchior
  • Rodrigo Argenta
  • Mariana M. Smith
  • Maurício S. Miura
  • Gabriel Kuhl

DOI:

https://doi.org/10.22491/2357-9730.125224

Keywords:

Laryngeal papillomatosis, human papilloma virus (HPV), carbon dioxide laser, adjuvant treatment

Abstract

Laryngeal papillomatosis is the most frequent benign neoplasm of the larynx, occurring in children and adults. It is caused by the human papilloma virus, especially types 6 and 11. The clinical course is unpredictable and recurrence is frequent in children. There have been reports of association between this disease and tracheobronchial tree and squamous cell carcinoma of the larynx. Papillomatosis is probably one of the
factors that can predispose a patient to the development of cancer, similarly to alcohol, tobacco, and radiation exposure.Treatment aims at maintaining airway patency and speech. Surgery with carbon dioxide laser is able to achieve this objective, however, without preventing recidivation. The low rates of surgical cure have been stimulating new research with chemotherapics. Unfortunately these have not been successful. Their main purpose is to reduce the extension of the disease and rates of recidivation, slowing down papilloma growth.The present study reviews pathophysiology, the clinical presentation and treatment aspects .

Downloads

Download data is not yet available.

Published

2022-06-13

How to Cite

1.
von Mülen C, Rigol C, Melchior R, Argenta R, M. Smith M, S. Miura M, et al. Papilomatose de laringe. Clin Biomed Res [Internet]. 2022 Jun. 13 [cited 2026 Aug. 3];19(2). Available from: https://seer.ufrgs.br/index.php/hcpa/article/view/125224

Issue

Section

Special Articles

Most read articles by the same author(s)

Similar Articles

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 > >> 

You may also start an advanced similarity search for this article.